Effective use of hormonal contraceptives. Part II: Combined hormonal injectables, progestogen-only injectables and contraceptive implants

Contraception

Volumn 73, Issue 2, 2006, Pages 125-133

  Chrisman, Camaryn E ^a   Curtis, Kathryn M ^b   Mohllajee, Anshu P ^b   Gaffield, Mary E ^b   Peterson, Herbert B ^c,d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c University of North Carolina at Chapel Hill   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Contraception; Evidence based review; Follicular development; Ovulation; Time factors

Indexed keywords

CONTRACEPTIVE AGENT; ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; INJECTABLE CONTRACEPTIVE AGENT; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ENANTATE; PROGESTERONE;

BIOAVAILABILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG IMPLANT; EMBASE; EVIDENCE BASED MEDICINE; HORMONAL CONTRACEPTION; HUMAN; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDLINE; MENSTRUAL CYCLE; OVARY FOLLICLE DEVELOPMENT; OVULATION INHIBITION; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; INJECTIONS; LEVONORGESTREL; PROGESTINS; TIME FACTORS;

EID: 30644458822     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.08.004     Document Type: Review

References (32)

1. L. Potter, D. Oakley, E. Leon-Wong, and R. Canamar Measuring compliance among oral contraceptive users Fam Plann Perspect 28 1996 154 158
2. A.P. Mohllajee, K.M. Curtis, R.G. Flanagan, W. Rinehart, M.L. Gaffield, and H.B. Peterson Keeping up with evidence: a new system for WHO's evidence-based family planning guidance Am J Prev Med 28 2005 483 490
3. R.P. Harris, M. Helfand, and S.H. Woolf Current methods of the US Preventive Services Task Force: a review of the process Am J Prev Med 20 2001 21 35
4. 2-cypionate: effects on ovarian function Fertil Steril 75 2001 744 748
5. C.A. Petta, M. Hays, and V. Brache Delayed first injection of the once-a-month injectable contraceptive containing 25 mg medroxyprogesterone acetate and 5 mg estradiol-cypionate: effects on cervical mucus Contraception 64 2001 363 368
6. A.R. Aedo, B.M. Landgren, E. Johannisson, and E. Diczfalusy Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations Contraception 31 1985 453 469
7. S. Bassol, C. Hernandez, M.P. Nava, A.M. Trujillo, and D.L. de la Cruz A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives Contraception 51 1995 307 311
8. J. Garza-Flores, V. Rodriguez, and G. Perez-Palacios A multicentered pharmacokinetic, pharmacodynamic study of once-a-month injectable contraceptives. I. Different doses of HRP112 and of DepoProvera Contraception 36 1987 441 457
9. M.H. Rahimy, and K.K. Ryan Lunelle monthly contraceptive injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension): assessment of return of ovulation after three monthly injections in surgically sterile women Contraception 60 1999 189 200
10. L. Bahamondes, P. Lavin, and G. Ojeda Return of fertility after discontinuation of the once-a-month injectable contraceptive Cyclofem Contraception 55 1997 307 310
11. C.A. Petta, A. Faundes, and T.R. Dunson Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function Fertil Steril 70 1998 817 820
12. C.A. Petta, A. Faundes, and T.R. Dunson Timing of onset of contraceptive effectiveness in Depo-Provera users: Part I. Changes in cervical mucus Fertil Steril 69 1998 252 257
13. T. Siriwongse, W. Snidvongs, P. Tantayaporn, and S. Leepipatpaiboon Effect of depo-medroxyprogesterone acetate on serum progesterone levels when administered on various cycle days Contraception 26 1982 487 493
14. C. Morroni, M. Grams, L. Tiezzi, and C. Westhoff Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection Contraception 70 2004 19 23
15. R. Sneed, C. Westhoff, C. Morroni, and L. Tiezzi A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection Contraception 71 2005 99 103
16. J. Balkus, and L. Miller Same-day administration of depot- medroxyprogesterone acetate injection: a retrospective chart review Contraception 71 2005 395 398
17. A. Ortiz, M. Hiroi, F.Z. Stanczyk, U. Goebelsmann, and D.R. Mishell Jr Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA J Clin Endocrinol Metab 44 1977 32 38
18. K. Fotherby, B.N. Saxena, and K. Shrimanker A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate Fertil Steril 34 1980 131 139
19. P.T. Lan, A.R. Aedo, B.M. Landgren, E. Johannisson, and E. Diczfalusy Return of ovulation following a single injection of depo-medroxyprogesterone acetate: a pharmacokinetic and pharmacodynamic study Contraception 29 1984 1 18
20. K. Fotherby, S. Koetsawang, and M. Mathrubutham Pharmacokinetic study of different doses of Depo Provera Contraception 22 1980 527 536
21. S. Bassol, J. Garza-Flores, and M.C. Cravioto Ovarian function following a single administration of depo-medroxyprogesterone acetate (DMPA) at different doses Fertil Steril 42 1984 216 222
22. B.N. Saxena, N. Dusitsin, M. Tankeyoon, and R.R. Chaudhury Return of ovulation after the cessation of depot-medroxyprogesterone acetate treatment in Thai women J Med Assoc Thai 63 1980 66 69
23. J. Garza-Flores, S. Cardenas, V. Rodriguez, M.C. Cravioto, V. Diaz-Sanchez, and G. Perez-Palacios Return to ovulation following the use of long-acting injectable contraceptives: a comparative study Contraception 31 1985 361 366
24. V. Brache, F. Alvarez, A. Faundes, L. Cochon, and F. Thevenin Effect of preovulatory insertion of Norplant implants over luteinizing hormone secretion and follicular development Fertil Steril 65 1996 1110 1114
25. T.R. Dunson, P.D. Blumenthal, and F. Alvarez Timing of onset of contraceptive effectiveness in Norplant implant users. Part I. Changes in cervical mucus Fertil Steril 69 1998 258 266
26. V. Brache, P.D. Blumenthal, F. Alvarez, T.R. Dunson, L. Cochon, and A. Faundes Timing of onset of contraceptive effectiveness in Norplant implant users. II. Effect on the ovarian function in the first cycle of use Contraception 59 1999 245 251
27. I. Sivin, D.R. Mishell Jr, and S. Diaz Prolonged effectiveness of Norplant® capsule implants: a 7-year study Contraception 61 2000 187 194
28. S. Gu, I. Sivin, and M. Du Effectiveness of Norplant® implants through seven years: a large-scale study in China Contraception 52 1995 99 103
29. N.M. Nour El-Dine, D.A. El-Moghazy, and A.R. El-Adawy Extension of use of the contraceptive implants, Norplant® and levonorgestrel rods to seven years Egyp Soc Obstet Gynecol 26 2000 377 393
30. L.S. Wan, A. Stiber, and L.Y. Lam The levonorgestrel two-rod implant for long-acting contraception: 10 years of clinical experience Obstet Gynecol 102 2003 24 26
31. I. Sivin, L. Wan, and S. Ranta Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants Contraception 64 2001 43 49
32. World Health Organization Selected practice recommendations for contraceptive use 2nd ed. 2005 World Health Organization Geneva